Table 2 Clinical characteristics and co-morbid chronic illness of study sample
From: Health-related quality of life of Southern Chinese with chronic hepatitis B infection
| Â | Uncomplicated CHB (n = 156) | Impaired LF (n = 102) | Cirrhosis (n = 139) | HCC (n = 123) | Overall (n = 520) |
|---|---|---|---|---|---|
Ever taken anti-viral treatment (%)†|  |  |  |  |  |
   No | 65.4 | 62.7 | 34.5 | 67.5 | 57.1 |
   Yes | 34.6 | 37.3 | 65.5 | 32.5 | 42.9 |
Liver function (%)†|  |  |  |  |  |
   Normal LF | 100.0 | 0.0 | 0.0 | 18.7 | 34.4 |
   Impaired LF without cirrhosis | 0.0 | 100.0 | 0.0 | 1.6 | 20.0 |
   Cirrhosis |  |  |  |  |  |
Child-Pugh A | NA | NA | 64.0 | 68.3 | 33.3 |
Child-Pugh B | NA | NA | 17.3 | 8.1 | 6.5 |
Child-Pugh C | NA | NA | 18.7 | 3.3 | 5.8 |
Duration of illness (mean, SD) | 12.8 ± 8.1 | 12.3 ± 8.7 | 11.6 ± 8.5 | 13.6 ± 10.6 | 12.6 ± 9.0 |
Biomarkers | Â | Â | Â | Â | Â |
   ALT, U/L (mean, SD)†| 27.4 ± 8.7 | 150.7 ± 306.5 | 48.2 ± 52.6 | 55.1 ± 47.3 | 67.8 ± 154.1 |
   AST, U/L (mean, SD)†| 24.1 ± 7.3 | 130.8 ± 272.0 | 48.2 ± 26.6 | 52.1 ± 38.8 | 57.4 ± 108.9 |
   Abnormal AFP, ng/ml (%)*†| 0.0 | 14.0 | 10.5 | 29.4 | 14.2 |
   Bilirubin, umol/L (mean, SD)†| 14.3 ± 7.0 | 20.1 ± 23.3 | 38.1 ± 56.5 | 18.4 ± 15.0 | 23.9 ± 35.3 |
Co-morbidity (%) | Â | Â | Â | Â | Â |
   Hypertension | 23.7 | 17.6 | 19.4 | 26.0 | 21.9 |
   Diabetes mellitus†| 6.4 | 3.9 | 19.4 | 17.9 | 12.1 |
   Heart disease | 3.8 | 3.9 | 6.5 | 5.7 | 5.0 |
   Stroke | 0.0 | 1.0 | 1.4 | 0.8 | 0.8 |
   Pulmonary disease | 6.4 | 2.0 | 5.0 | 3.3 | 4.4 |
   Joint disease | 3.2 | 3.9 | 3.6 | 3.3 | 3.5 |
   Psychological disease | 4.5 | 4.9 | 3.6 | 8.9 | 5.4 |
   Others | 12.8 | 10.8 | 11.5 | 19.5 | 13.7 |
   Any chronic illness†| 38.5 | 31.4 | 51.8 | 53.7 | 44.2 |